HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Robotic surgery ‘here to stay’ despite concerns about cost, lack of data
-
- HPV screening more protective against cervical cancer than cytology
- FDA grants priority review for ramucirumab as gastric cancer treatment
- Imaging results demonstrate everything that glitters is not gold Munir Ghesani, MD, FACNM; Carlos Benitez, MD; Yi Chen Zhang, MD
- Obesity increased risk for pancreatic cancer mortality
- Guideline-recommended colorectal screening may miss cancer in patients at increased risk
- Nivolumab induced responses in melanoma refractory or naive to ipilimumab
- Oncogenic NTRK1 rearrangement identified in lung cancer
- Patients unaware of screening’s risk for overdiagnosis, overtreatment
-
- Tolvaptan corrected hyponatremia in hospitalized patients with cancer
- PSA testing for older patients varied greatly by primary care physician
- Bladder cancer diagnosis delayed in women after hematuria presentation
- Central line maintenance care bundle reduced infections, bacteremia
- Chemotherapy linked to improved median survival in elderly patients with SCLC
- Chemotherapy offered limited benefit for advanced chondrosarcomas
- Early tumor shrinkage after cetuximab predicts survival in metastatic colorectal cancer
- FOBT reduced mortality from colorectal cancer, not other causes
-
- Health-related QOL helped predict survival in 11 cancer types
- Intracranial, extracranial metastases in BRAF-mutant melanoma respond similarly to dabrafenib
- Most patients want physician guidance on genetic testing
- Radiotherapy after local excision decreased breast cancer recurrence
- Type of breast cancer irradiation linked to risk for CVD
- Vintafolide plus pegylated liposomal doxorubicin improved outcomes in ovarian cancer
- Breslow thickness, Clark level, ulceration predict sentinel lymph node metastasis in thin melanomas
- Moderate severe dysplasia at resection margin may warrant additional therapy
-
- Center hires deputy physician-in-chief
- City of Hope hires scientific officer
- Institute hires chief of medical oncology
- Nurses association elects new president
- Penn names VP of precision medicine
- Pharmacy group elects new president
- Nab-paclitaxel significantly extended PFS in metastatic melanoma
- CTL019 therapy induced response in CLL, ALL
-
- Novel agent reduced time to resolution of vaso-occlusive crisis
- AGS-003 plus sunitinib shows promise in metastatic renal cell carcinoma
- Anti-CD19 T cells show promise in adult, pediatric ALL
- Bile VEGF levels distinguish pancreatic cancer from other biliary stricture causes
- Investigational immunotherapy associated with high survival rate in advanced melanoma
- Oral PI3K inhibitor demonstrates activity in CLL
- PARP inhibitor shows promise in treatment of breast, ovarian cancers
- Reduced-intensity HSCT recipients spared from post-HSCT cognitive impairment
-
- Role of genetics in warfarin dosing a source of debate
- Siltuximab demonstrated clinical benefit in patients with multicentric Castleman disease
- TILs may predict response to trastuzumab
- Radiotherapy may be unnecessary for older patients with breast cancer
- Up-regulation of gamma-globin may benefit patients with beta-thalassemia, sickle cell disease
- TCH effective as adjuvant therapy for HER-2–positive breast cancer